BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8324219)

  • 1. Control of programmed cell death in normal and leukemic cells: new implications for therapy.
    Sachs L; Lotem J
    Blood; 1993 Jul; 82(1):15-21. PubMed ID: 8324219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes.
    Lotem J; Sachs L
    Leukemia; 1996 Jun; 10(6):925-31. PubMed ID: 8667646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells.
    Bhalla K; Tang C; Ibrado AM; Grant S; Tourkina E; Holladay C; Hughes M; Mahoney ME; Huang Y
    Blood; 1992 Dec; 80(11):2883-90. PubMed ID: 1450413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The control of hematopoiesis and leukemia: from basic biology to the clinic.
    Sachs L
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4742-9. PubMed ID: 8643473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.
    Delia D; Aiello A; Formelli F; Fontanella E; Costa A; Miyashita T; Reed JC; Pierotti MA
    Blood; 1995 Jan; 85(2):359-67. PubMed ID: 7811993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma inhibits apoptosis induced by wild-type p53, cytotoxic anti-cancer agents and viability factor deprivation in myeloid cells.
    Lotem J; Sachs L
    Leukemia; 1995 Apr; 9(4):685-92. PubMed ID: 7723404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells.
    Selvakumaran M; Lin HK; Sjin RT; Reed JC; Liebermann DA; Hoffman B
    Mol Cell Biol; 1994 Apr; 14(4):2352-60. PubMed ID: 8139540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional aspects of apoptosis in hematopoiesis and consequences of failure.
    McKenna SL; Cotter TG
    Adv Cancer Res; 1997; 71():121-64. PubMed ID: 9111865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
    Kozopas KM; Yang T; Buchan HL; Zhou P; Craig RW
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3516-20. PubMed ID: 7682708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hemopoietic growth factors G-CSF and pIXY 321 on the activity of high dose Ara-C in human myeloid leukemia cells.
    Bhalla K; Tourkina E; Huang Y; Tang C; Mahoney ME; Ibrado AM
    Leuk Lymphoma; 1993; 10 Suppl():123-31. PubMed ID: 7683227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle.
    Ryan JJ; Prochownik E; Gottlieb CA; Apel IJ; Merino R; Nuñez G; Clarke MF
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5878-82. PubMed ID: 8016082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest.
    Guillouf C; Graña X; Selvakumaran M; De Luca A; Giordano A; Hoffman B; Liebermann DA
    Blood; 1995 May; 85(10):2691-8. PubMed ID: 7742528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-colony stimulating factor induced apoptosis in radiation-induced murine leukemia cell line.
    Handa A; Kashimura T; Kawano N; Yamamoto A; Yoshida S; Jinnai I; Murohashi I; Bessho M; Hirashima K
    Leukemia; 1997 Apr; 11 Suppl 3():387-8. PubMed ID: 9209400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Myc sensitization to oxygen deprivation-induced cell death is dependent on Bax/Bak, but is independent of p53 and hypoxia-inducible factor-1.
    Brunelle JK; Santore MT; Budinger GR; Tang Y; Barrett TA; Zong WX; Kandel E; Keith B; Simon MC; Thompson CB; Hay N; Chandel NS
    J Biol Chem; 2004 Feb; 279(6):4305-12. PubMed ID: 14627695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2.
    Deng G; Podack ER
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2189-93. PubMed ID: 8460122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
    Lisovsky M; Estrov Z; Zhang X; Consoli U; Sanchez-Williams G; Snell V; Munker R; Goodacre A; Savchenko V; Andreeff M
    Blood; 1996 Nov; 88(10):3987-97. PubMed ID: 8916965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate.
    Calabresse C; Venturini L; Ronco G; Villa P; Degos L; Belpomme D; Chomienne C
    Biochem Biophys Res Commun; 1994 May; 201(1):266-83. PubMed ID: 8198584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.